Drug Information
Drug General Information | Top | |||
---|---|---|---|---|
Drug ID |
D0P0BY
|
|||
Drug Name |
Codrituzumab
|
|||
Indication | Hepatic metastasis [ICD-11: 2D80; ICD-10: C78.7] | Phase 2 | [1] | |
Company |
GenentechSouth San Francisco, CA
|
Target and Pathway | Top | |||
---|---|---|---|---|
Target(s) | Glypican-3 (GPC3) | Target Info | Inhibitor | [1] |
KEGG Pathway | Proteoglycans in cancer | |||
NetPath Pathway | IL2 Signaling Pathway | |||
Pathway Interaction Database | Glypican pathway | |||
Glypican 3 network | ||||
Reactome | A tetrasaccharide linker sequence is required for GAG synthesis | |||
HS-GAG degradation | ||||
Retinoid metabolism and transport | ||||
WikiPathways | Visual phototransduction |
References | Top | |||
---|---|---|---|---|
REF 1 | Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA) |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.